Top Story

Santen microshunt study results lead news of the week

September 7, 2019

iSTAR Medical completes Series C funding round

September 6, 2019
iSTAR Medical has completed 40 million euros in Series C financing to be used in the development of its MINIject device for the treatment of glaucoma, according to a…
Meeting News

Glaucoma associated with DSAEK failure

September 3, 2019
COEUR D’ALENE, Idaho — Glaucoma was strongly associated with higher failure rates after Descemet’s stripping automated endothelial keratoplasty…

DE-128 microshunt reduced IOP, medications in study

August 30, 2019
A multicenter study found the DE-128 microshunt implanted intraoperatively with 0.2 mg/mL concentration of mitomycin C effectively reduced IOP in patients with primary…
More Headlines »
Clinical Science

Glaucoma Filtration Surgery Following Sustained Elevation of Intraocular Pressure Secondary to Intravitreal Anti-VEGF Injections

Ophthalmic Surgery, Lasers and Imaging Retina, July 2012, Volume 43 Issue 4
To document cases of sustained elevation of intraocular pressure (IOP) while receiving intravitreal anti-vascular…
More »

Latanoprostene Bunod and its Nitric Oxide Moiety

This activity is supported by educational grants from Alcon Laboratories, Inc.; Bausch + Lomb; Glaukos Corporation; and Novartis Pharmaceuticals Corporation.

This educational activity will discuss modulation of aqueous humor outflow by nitric oxide and the efficacy of…
More »
Meeting News

VIDEO: Mnemonic helps ensure ocular surface integrity in glaucoma patients

August 30, 2019
More »